Liver Cancer (DBCOND0028488)

Identifiers

Synonyms
Cancer, Liver / Cancer Liver / Gastrointestinal Cancers - Liver / Cancer of the Liver / Hepatocellular Cancer (HCC) / Liver, cancer of / Cancer, Hepatocellular / Cancer of Liver / Hepatocellular Cancer / Liver cancer / Malignant neoplasm of liver, not specified as primary or secondary / Hepatic cancer / Hepatic tumour malignant / Hepatic tumor malignant / Malignant liver tumour / Malignant liver tumor / Hepatic neoplasm malignant NOS / Malignant hepatic neoplasm / Hepatic neoplasms malignant / Hepatic neoplasm malignant / Malignant neoplasm of liver (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Uracil
An antineoplastic agent used in combination with tegafur to treat various cancers, including breast, prostate, and liver cancer.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06391749
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)No drug interventionsNot AvailableNot Availablerecruiting
NCT04708483
DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic CriteriaNo drug interventionsdiagnosticNot Availableunknown_status
NCT05227261
Early Detection of Five Common Cancers Using the ctDNA Analysing TestNo drug interventionsNot AvailableNot Availablerecruiting
NCT03301493
Genomic Testing and Resulting Medical DecisionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03033615
PixelShine vs. Iterative Reconstruction (IR) Processing of CT ImagesNo drug interventionsdiagnosticNot Availableunknown_status
NCT03185416
Early Palliative Care Integration in Interventional Cancer CareNo drug interventionspreventionNot Availablewithdrawn
NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05745558
PREoPerAtive pREhabilitation in Patients With Head and Neck Cancer or Liver Cancer (PREPARE)No drug interventionspreventionNot Availablerecruiting
NCT02045381
Optimization of MRI for Radiation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesNo drug interventionssupportive_careNot Availablerecruiting
NCT02618447
4D Phase Contrast MR: Hypertrophy in Liver CancerNo drug interventionsdevice_feasibilityNot Availableterminated
NCT00669136
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinomatreatment1terminated
NCT01099631
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic SpreadNo drug interventionstreatment1completed
NCT03753789
Ablation Confirmation StudyNo drug interventionstreatmentNot Availableterminated
NCT00422877
Taxoprexin® Treatment for Advanced Primary Cancers of the LiverNo drug interventionstreatment2terminated
NCT04107766
NOLA (NeuWave Observational Liver Ablation) RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00152087
A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.No drug interventionstreatment2unknown_status
NCT00058487
Epirubicin and Thalidomide in Treating Patients With Liver Cancertreatment2completed
NCT05322187
Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapytreatment2 / 3unknown_status
NCT00243633
Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)No drug interventionsdiagnosticNot Availablecompleted
NCT03998033
Study of ET140202 T Cells in Adults With Advanced Hepatocellular CarcinomaNo drug interventionstreatment1terminated
NCT03766633
Accuracy of the LiverVision® Semi-automated Liver Volumetry SoftwareNo drug interventionsNot AvailableNot Availableunknown_status
NCT05600933
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05411133
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer PatientsNo drug interventionstreatment1recruiting
NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.No drug interventionstreatment1completed
NCT03891654
Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer PatientsNo drug interventionsdiagnostic0completed
NCT05475054
Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classesNo drug interventionsNot AvailableNot Availablecompleted
NCT00881751
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancertreatment2completed
NCT02649153
Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic ResectionNo drug interventionstreatment3completed
NCT00740753
Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an OptionNo drug interventionstreatmentNot Availablecompleted
NCT05497453
A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogenetreatment1 / 2recruiting
NCT01935453
A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat CancerNo drug interventionstreatment1completed
NCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacNo drug interventionstreatmentNot Availablerecruiting
NCT04106453
Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo TrialNo drug interventionsotherNot Availablecompleted
NCT01313377
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgerytreatment3completed
NCT00623077
MT2004-30: Tomotherapy for Solid Tumorstreatment1terminated
NCT00021047
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumortreatment1 / 2completed
NCT04221347
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCCNo drug interventionsNot AvailableNot Availableunknown_status
NCT04309747
A Prospective, Multicenter Clinical Trial of Safety and Effectiveness of Nanosecond Knife Ablation for Liver CancerNo drug interventionstreatmentNot Availableunknown_status
NCT04707547
Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapytreatment4completed
NCT00003147
Gene Therapy in Treating Patients With Cancer of The LiverNo drug interventionstreatment1terminated
NCT04682847
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic CancersNot AvailableNot Availableactive_not_recruiting
NCT03595345
A Worldwide Score for Hepatocellular Cancer and Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT02069145
Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancertreatment1completed
NCT05931445
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06175845
Endoscopic Radiofrequency Ablation for Unresectable CholangiocarcinomaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06536998
Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach(Radiogenomics-Liver)No drug interventionsNot AvailableNot Availablerecruiting
NCT00276705
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancertreatment2unknown_status
NCT01264705
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancertreatment1 / 2completed
NCT05723705
Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05146297
Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01230697
Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)Not AvailableNot Availableunknown_status
NCT00293397
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT06369597
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic SurgeryNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03317483
DEB-TACE Treatment in 367 Liver Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02941861
Factors Influencing the 3-Year Recurrence of Liver Carcinoma After SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05964361
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer PatientsNo drug interventionstreatment1 / 2recruiting
NCT06315361
DIAbetes and NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01151761
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantationtreatment2terminated
NCT02654028
Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After ResectionNo drug interventionssupportive_careNot Availablecompleted
NCT05872828
Cross-sectional Study of Chinese Liver Cancer PatientsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01356628
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancertreatment2active_not_recruiting
NCT01286428
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic ProceduresNo drug interventionsNot AvailableNot Availablecompleted
NCT05281211
Nutrition and Exercise Prehabilitation to Reduce Morbidity Following Major Liver Surgery in Sarcopenic PatientsNo drug interventionspreventionNot Availablerecruiting
NCT01539993
Prospective Liver StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00658593
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancertreatment3terminated
NCT03804593
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablecompleted
NCT00009893
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancertreatment2completed
NCT00151671
Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver CancerNo drug interventionsprevention2 / 3terminated
NCT00666978
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smokingtreatment4completed
NCT04014478
A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer PainNo drug interventionstreatmentNot Availableunknown_status
NCT03131778
The Inflammatory Response to Stress and Angiogenesis in Liver ResectionNo drug interventionstreatmentNot Availablecompleted
NCT02632188
Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular CarcinomaNo drug interventionstreatment1 / 2unknown_status
NCT05369988
VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERYNo drug interventionsNot AvailableNot Availableunknown_status
NCT00888407
Community-based Hepatitis B Interventions for Hmong AdultsNo drug interventionspreventionNot Availablecompleted
NCT01581307
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Metstreatment2completed
NCT02599909
Gut Microbiota in People With Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablewithdrawn
NCT02449109
Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver CarcinomaNo drug interventionstreatment1 / 2completed
NCT02966509
Engagement of Patients With Advanced CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT05123209
Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver TumorsNo drug interventionstreatment1unknown_status
NCT00410956
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgerytreatment2completed
NCT02721056
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver CancersNo drug interventionstreatment1 / 2terminated
NCT00717756
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trialtreatment2completed
NCT05153785
Perioperative Intravenous Lidocaine in Liver Surgerytreatment2 / 3recruiting
NCT00183885
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinomatreatment2unknown_status
NCT03445585
Biobank for Cholestatic Liver Diseases.No drug interventionsNot AvailableNot Availablerecruiting
NCT00002485
Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00002515
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancertreatment2completed
NCT00581815
Spectroscopy With Surface Coils and DecouplingNo drug interventionsdiagnostic1completed
NCT05953337
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)No drug interventionstreatmentNot Availablerecruiting
NCT05816837
Displacement Distance and Stabilization Time for Liver Fiducial MarkerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06409637
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantationprevention1 / 2not_yet_recruiting
NCT02646137
Single Session Combined Locoregional Therapies for Hepatocellular CarcinomaNo drug interventionstreatment3unknown_status
NCT00373737
Microarray Analysis of Gene Expression in Liver TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT03111732
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)treatment2completed
NCT03153332
Value of 3D Printing for Comprehension of Liver Surgical AnatomyNo drug interventionsNot AvailableNot Availablecompleted
NCT04377932
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsNo drug interventionstreatment1recruiting
NCT01749332
A Pilot Study of Perihepatic Phlebotomy During Hepatic ResectionsNo drug interventionsdiagnosticNot Availablecompleted
NCT03026452
Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver CancerNo drug interventionstreatment1 / 2unknown_status
NCT05876052
HOPE to Reduce Tumour Recurrence After LT In Patients With HCCNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02239900
Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumorstreatment1completed
NCT00605800
Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic FunctionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06212700
PRIORITY-CONNECT 2 Pilot TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT06050200
TANGO-LIVER Three Arm Nuclear Growth Observation in Liver SurgeryNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT04134559
Checkpoint Inhibition In Pediatric Hepatocellular Carcinomatreatment2recruiting
NCT01180959
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapytreatment2completed
NCT00036959
ABT-751 in Treating Young Patients With Refractory Solid Tumorstreatment1completed
NCT02829359
Effects of Antiviral Therapy on HBV Reactivationtreatment2 / 3completed
NCT01005875
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular CarcinomatreatmentNot Availableterminated
NCT03143270
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancertreatment0active_not_recruiting
NCT04825470
Liver Transplantation for Unresectable GIST Liver MetastasesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01864070
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Diseasetreatment1withdrawn
NCT06341270
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing HepatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT01813942
Platform for Medical Information Extraction From Incomplete DataNo drug interventionsNot AvailableNot Availableunknown_status
NCT06139042
Early-stage Detection of LIver, Biliary tRAct and pancReatic CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNo drug interventionstreatment1completed
NCT04657042
4D-MRI for Precision MedicineNo drug interventionsNot AvailableNot Availablerecruiting
NCT06084299
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancertreatment1recruiting
NCT01075399
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in TumorsNo drug interventionsNot Available2completed
NCT02329106
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic DomeNo drug interventionstreatmentNot Availablecompleted
NCT03592706
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct TherapyNo drug interventionstreatment2 / 3unknown_status
NCT04868149
Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPSNo drug interventionstreatment3recruiting
NCT05694949
Main Postoperative Complications After COVID-19No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06130436
Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing HepatectomyNo drug interventionstreatmentNot Availablecompleted
NCT00293436
Celecoxib and Erlotinib in Treating Patients With Liver Cancertreatment1 / 2withdrawn
NCT05039736
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapytreatment2withdrawn
NCT00004136
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver CancerNo drug interventionstreatment2completed
NCT05492136
Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence?No drug interventionspreventionNot Availablerecruiting
NCT00430313
Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or OxaliplatinNo drug interventionssupportive_careNot Availablewithdrawn
NCT04769713
Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedurestreatment4recruiting
NCT00007813
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumorstreatment1completed
NCT02687113
Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US FusionNo drug interventionstreatmentNot Availablecompleted
NCT02471313
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After ChemoembolizationNo drug interventionsdiagnostic2completed
NCT01862718
Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic NeoplasmsNo drug interventionstreatment1terminated
NCT06440018
INSPIRE: A Multi-Cancer Early Detection StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06181318
Quantitative MRI and Outcomes of Liver ResectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03223818
The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT03958019
Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05532319
HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCCtreatment2completed
NCT00132041
Radiofrequency Ablation in Treating Patients With Liver Cancer and CirrhosisNo drug interventionstreatmentNot Availablecompleted
NCT05430841
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CTNo drug interventionsdiagnosticNot Availableunknown_status
NCT01042041
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancertreatment1completed
NCT02202317
Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver TumorsNo drug interventionsscreeningNot Availablecompleted
NCT06084234
National Liver Cancer Screening TrialNo drug interventionsscreening4recruiting
NCT00027534
Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerNo drug interventionstreatment1completed
NCT01071434
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming TumorsNo drug interventionsNot AvailableNot Availableterminated
NCT01494324
Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of OutcomeNo drug interventionsdiagnosticNot Availablerecruiting
NCT00557024
Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular CarcinomaNo drug interventionstreatment4unknown_status
NCT04107324
ARAPS Study on Accelerated Liver RegenerationNo drug interventionstreatmentNot Availableunknown_status
NCT04466124
Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam TherapyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01171924
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumorstreatment1completed
NCT03744624
Application of 3D Printing in Laparoscopic Surgery of Liver TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT00957424
Acceptability of Less Harmful Alternatives to CigarettesNot AvailableNot Availablecompleted
NCT00034216
Collection of Blood From Patients With CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00128596
Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgerytreatment2completed
NCT02563158
Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCCNo drug interventionstreatmentNot Availableunknown_status
NCT04731558
Pre- vs Postoperative Thromboprophylaxis for Liver Resectionprevention4recruiting
NCT00870558
Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancertreatment3completed
NCT03383458
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablationtreatment3active_not_recruiting
NCT00304135
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgerytreatment2 / 3completed
NCT02425735
Safety and Efficiency of γδ T Cell Against Hepatocellular Liver CancerNo drug interventionstreatment1 / 2completed
NCT04933435
Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT06036563
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA SequencingNo drug interventionsNot AvailableNot Availablerecruiting
NCT00469963
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by SurgeryNo drug interventionstreatmentNot Availableterminated
NCT03199586
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignanciestreatment1completed
NCT05709886
A Prospective, Single-arm, Multicenter Clinical Trial of Safety and Effectiveness of EUS-LA for Liver CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00782886
Evaluation of Image-Guided Liver Surgical System for Resection of Liver CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00019786
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastasestreatment2completed
NCT05616039
I-FIGS Feasibility StudyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02575339
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinomatreatment1 / 2terminated
NCT00049322
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgerytreatment2completed
NCT00250822
Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microlitertreatment2completed
NCT00451022
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00605722
A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.treatment2completed
NCT05540925
Vascular Invasion Signatures in cfDNA Support Re-staging of Liver CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00514930
Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the LiverNo drug interventionstreatment1 / 2unknown_status
NCT01292330
A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional SupportNo drug interventionssupportive_careNot Availableunknown_status
NCT06257030
The AMARA (As Much As Reasonably Achievable) StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00589030
Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryNo drug interventionsNot AvailableNot Availableno_longer_available
NCT06091930
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6treatment1recruiting
NCT01213030
Clinical Evaluation of the New Hypoxia Imaging Agent HX4No drug interventionsdiagnostic1 / 2completed
NCT05638048
Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer PatientsNo drug interventionspreventionNot Availablecompleted
NCT00244348
Hepatic Artery Infusion With Oxaliplatintreatment1 / 2withdrawn
NCT02568748
Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCCNo drug interventionstreatment3unknown_status
NCT02662348
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive Systemtreatment1unknown_status
NCT00542048
A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic MetastasesNo drug interventionsbasic_science2completed
NCT00003557
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancertreatment2completed
NCT05829057
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1No drug interventionstreatment1recruiting
NCT00257426
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancertreatment2completed
NCT06353126
DEB-TACE Prior to Liver Transplantation in the Treatment of HCCNo drug interventionstreatment2not_yet_recruiting
NCT05996666
Primary Liver Cancer Early DetectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00987766
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancertreatment1completed
NCT03585166
Nursing Fro Laparoscopic vs. Open HepatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04150874
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAENo drug interventionsdiagnostic0terminated
NCT00185874
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastasestreatment1terminated
NCT05992220
Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasiontreatment2recruiting
NCT04931420
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid LevelsNo drug interventionstreatment2withdrawn
NCT02960620
Therasphere for Unresectable Primary or Secondary Liver NeoplasiaNo drug interventionsNot AvailableNot Availableno_longer_available
NCT04476082
Nutrition in Gastrointestinal TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00949182
Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgerytreatment2completed
NCT00030082
Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancertreatment1completed
NCT01556282
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein ThrombosisNo drug interventionstreatmentNot Availablecompleted
NCT02893982
High Dose Rate Brachyablation of Primary Liver LesionsNo drug interventionstreatment1terminated
NCT04053231
Hepatocarcinoma Recurrence on the Liver Study - Part2No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02292173
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancertreatment1completed
NCT02333773
Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor EmboliNo drug interventionstreatmentNot Availablecompleted
NCT01210027
A Study of Radiation Toxicity in the Liver Using MRI-Based PerfusionNo drug interventionsNot AvailableNot Availablecompleted
NCT00079027
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)treatment3unknown_status
NCT05183776
Clinical Validation of a Fractional Administration Device for Holmium-166 SIRTNo drug interventionstreatmentNot Availablecompleted
NCT02431676
Survivorship Promotion In Reducing IGF-1 Trialprevention2completed
NCT00716976
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancysupportive_care3completed
NCT04926376
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable HCC and mCRCNo drug interventionstreatmentNot Availablecompleted
NCT01438476
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or PancreasNo drug interventionstreatment3completed
NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancertreatment1completed
NCT00247260
Safety of 32P BioSilicon in Patients With Hepatocellular CarcinomaNo drug interventionstreatment2unknown_status
NCT05176860
Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision RadiotherapyNo drug interventionsotherNot Availablecompleted
NCT05942560
Effects of CBT-Based Intervention Among Patients With Liver CancerNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01401894
Perception Prognosis, Goals of Treatment, and CommunicationNo drug interventionsNot AvailableNot Availablecompleted
NCT04705194
Hepatectomy Risk Assessment With Functional Magnetic Resonance ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT00900094
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06196294
GPC3/Mesothelin-CAR-γδT Cells Against Cancerstreatment1recruiting
NCT03256994
CIRSE Registry for SIR-Spheres in France (CIRT-FR)No drug interventionsNot AvailableNot Availablecompleted
NCT00527891
Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00054262
T900607 in Treating Patients With Unresectable Liver Cancertreatment2completed
NCT05719480
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03843229
Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver CancerNo drug interventionstreatment4unknown_status
NCT00858429
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastasestreatment1completed
NCT00005629
Vaccine Therapy in Treating Patients With Liver CancerNo drug interventionstreatment1 / 2completed
NCT00077389
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastomatreatment2unknown_status
NCT05989789
Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT00836992
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02465892
Pillars4Life TrialNo drug interventionssupportive_careNot Availablecompleted
NCT00950144
Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00093444
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumorstreatment1completed
NCT01497444
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgerytreatment1completed
NCT00003044
Chemotherapy in Treating Patients With Liver Cancertreatment2unknown_status
NCT00303940
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumorstreatment1completed
NCT01061840
Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced CancerNo drug interventionstreatment1completed
NCT03063840
Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic VesselsNo drug interventionstreatmentNot Availablewithdrawn
NCT05160740
Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver CancertreatmentNot Availablerecruiting
NCT00739167
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04739501
Trans-arterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Study of Different Outcomes and Their Predictive FactorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00768001
Genetic Analysis of Liver CancerNo drug interventionsNot AvailableNot Availableterminated
NCT06482801
Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via ITtreatment2recruiting
NCT01388101
Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)No drug interventionsdiagnosticNot Availableunknown_status
NCT05471401
GI Organ Tracking Via Balloon ApplicatorsNo drug interventionsdevice_feasibilityNot Availablewithdrawn
NCT00774501
The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During RadiotherapyNo drug interventionstreatmentNot Availablecompleted
NCT01178801
Sharable Knowledge Mining PlatformNo drug interventionsNot AvailableNot Availableunknown_status
NCT01545804
Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinomatreatment2completed
NCT03723304
The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00019604
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver CancerNo drug interventionstreatment2terminated
NCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04690972
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05598268
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.treatment1 / 2recruiting
NCT03784469
Effectiveness of Positioning on Back Pain After TACE Among Patients With HCCNo drug interventionsotherNot Availablecompleted
NCT03965546
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancertreatment0unknown_status
NCT02271646
Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors AblationpreventionNot Availablecompleted
NCT02716012
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancertreatment1active_not_recruiting
NCT00003912
Chemotherapy in Treating Children With Liver Cancertreatment3completed
NCT02349412
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversNo drug interventionssupportive_care3completed
NCT04341012
Breath Analysis Based Disease Biomarkers of COVID-19 and Other DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT04842812
Engineered TILs/CAR-TILs to Treat Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT00191412
A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Livertreatment2completed
NCT00436410
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancertreatment0completed
NCT00006010
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancertreatment2completed
NCT05339581
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver TransplantationtreatmentNot Availableunknown_status
NCT05781581
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 InfectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02753881
Pharmacokinetics of Doxorubicin in cTACE of Liver Cancertreatment1completed
NCT03228095
Volatiles in Breath and Headspace Analysis - Diagnostic MarkersNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05200195
Deep Learning Model for the Prediction of Post-LT HCC RecurrenceNo drug interventionsNot AvailableNot Availablecompleted
NCT03516695
RadioEmbolization for the ADvancement of Y90 Glass Microspheres RegistryNo drug interventionsNot AvailableNot Availableterminated
NCT05095714
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.No drug interventionsscreeningNot Availablenot_yet_recruiting
NCT00003714
Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancertreatment2withdrawn
NCT05032014
Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver CancerNo drug interventionspreventionNot Availableunknown_status
NCT00825955
Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatmenttreatment3completed
NCT05342350
International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00728650
A Retrospective Review of Malignant Liver TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT05369650
To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in PatientstreatmentNot Availableunknown_status
NCT04288323
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosisscreening4recruiting
NCT06408623
Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancertreatment2not_yet_recruiting
NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT06345508
Early Detection of Liver Cancer by QUSNo drug interventionsNot AvailableNot Availablerecruiting
NCT06478108
Interventional Software for Multi-immunotherapy of Solid TumorsNo drug interventionstreatment2 / 3recruiting
NCT00004108
DX-8951f in Treating Patients With Liver Cancertreatment2completed
NCT00365508
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smokingtreatment4completed
NCT00568308
Phase III Study of PI-88 in Post-resection Hepatocellular Carcinomatreatment3terminated
NCT00005938
DX-8951f in Treating Patients With Biliary Cancertreatment2completed
NCT03059238
Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Proceduretreatment3completed
NCT02523443
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver ResectionNo drug interventionstreatment3active_not_recruiting
NCT04348643
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerNo drug interventionstreatment1 / 2unknown_status
NCT00539643
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular CarcinomaNo drug interventionstreatment2completed
NCT00556803
TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular CarcinomaNo drug interventionstreatment4unknown_status
NCT05184790
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New TechnologyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00511264
Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal TractNo drug interventionsNot AvailableNot Availablecompleted
NCT00867321
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancertreatment1 / 2completed
NCT00537121
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancertreatment1completed
NCT01906021
Study of New Software Used During AblationsNo drug interventionsdiagnosticNot Availablecompleted
NCT06326502
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular CarcinomaNo drug interventionstreatment1recruiting
NCT06179602
Prospective Cohort Study on Thermal Ablation of Malignant Liver TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00471484
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgerytreatment2unknown_status
NCT04028479
The Registry of Oncology Outcomes Associated With Testing and TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT02321579
Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant CapacitiesNo drug interventionspreventionNot Availableunknown_status
NCT02461979
The Role of the Vitamin D Receptor Gene Polymorphisms in HepatocarcinogenesisNo drug interventionsotherNot Availableunknown_status
NCT02133079
Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96No drug interventionstreatment1 / 2unknown_status
NCT05727787
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCCNo drug interventionstreatmentNot Availablerecruiting
NCT00376987
Zinc Supplements in Lowering Cadmium Levels in SmokersNo drug interventionsprevention2completed
NCT01877187
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancerother2completed
NCT02291133
Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)treatment1 / 2completed
NCT05806333
[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG AvidityNo drug interventionsdiagnosticNot Availablerecruiting
NCT04206254
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver CancerNo drug interventionstreatment2 / 3unknown_status
NCT00109954
Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgerytreatment3completed
NCT02821754
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)treatment2completed
NCT03813953
The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver ResectionNo drug interventionsotherNot Availablecompleted
NCT01618253
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinomatreatment1withdrawn
NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskNo drug interventionsNot AvailableNot Availablerecruiting
NCT01238653
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic ProceduresNo drug interventionsNot AvailableNot Availableterminated
NCT00574977
Safety Study of Modified Vaccinia Virus to Cancertreatment1completed
NCT00543777
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver DiseaseNo drug interventionsdiagnostic1 / 2completed
NCT00582647
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05738447
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular CarcinomaNo drug interventionstreatment1recruiting
NCT00373347
Identification of New Serum Diagnostic Markers of Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT06563947
Single Arm Clinical Trial (Gut Microbiota and HCC)No drug interventionstreatment2not_yet_recruiting
NCT00230347
Evaluation of Stereotactic Radiosurgery For Liver MalignanciesNo drug interventionstreatment1completed
NCT00006198
Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancertreatment2unknown_status
NCT00040898
Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically RemovedNo drug interventionstreatment2completed
NCT00976898
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and CholangiocarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT05363605
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumourstreatment1 / 2terminated
NCT03396705
Liver RegenerationNo drug interventionsNot AvailableNot Availableterminated
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00483405
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancertreatment2completed
NCT00554905
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular CarcinomaNo drug interventionstreatment4unknown_status
NCT00073905
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancersupportive_care2completed
NCT03756597
PAN-study: Pan-Cancer Early Detection Study (PAN)No drug interventionsNot AvailableNot Availablecompleted
NCT05767697
Genomics and Prognosis in GI CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT03981497
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver NeoplasmsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00005997
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancertreatment2terminated
NCT05184283
Utilization of MAsS in Patients Undergoing LT for HCCNo drug interventionsNot AvailableNot Availableterminated
NCT00553683
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancertreatment1 / 2unknown_status
NCT03166683
Standard of Care Versus Hemopatch® During Liver ResectionNo drug interventionsotherNot Availableunknown_status
NCT01596283
Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver ResectionNo drug interventionstreatment3completed
NCT04215861
Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06227728
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.No drug interventionsNot AvailableNot Availablerecruiting
NCT00514228
Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgerytreatment2completed
NCT00607828
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver CancerNo drug interventionstreatmentNot Availablecompleted
NCT00030511
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancertreatment2terminated
NCT05517811
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03184493
Celebrex and Metformin for Postoperative Hepatocellular Carcinomatreatment3unknown_status
NCT04511793
Hepatic Artery Infusion (HAI) Program at Duke UniversityNo drug interventionstreatmentNot Availablewithdrawn
NCT06584071
A Clinical Trial to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCCtreatment1 / 2not_yet_recruiting
NCT02102971
Observational Study of Biomarker During Liver SurgeryNo drug interventionsNot AvailableNot Availableterminated
NCT00728078
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinomatreatment2 / 3unknown_status
NCT00039078
Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by SurgeryNo drug interventionstreatment2withdrawn
NCT05444478
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular CarcinomatreatmentNot Availablerecruiting
NCT06263088
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.No drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal MalignanciesNo drug interventionssupportive_careNot Availablecompleted
NCT00003907
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Livertreatment2completed
NCT03405909
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00076609
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinomatreatment1 / 2completed
NCT00361309
SU011248 in Advanced Hepatocellular Carcinomatreatment2completed
NCT00486356
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancertreatment1completed
NCT02932956
Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)treatment1active_not_recruiting
NCT02545556
Liver Cancer HepaSphere Combined With CryosurgeryNo drug interventionstreatment1 / 2completed
NCT01219985
Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the LiverNo drug interventionsdiagnosticNot Availablecompleted
NCT01932385
Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinomatreatment2 / 3completed
NCT00507585
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastintreatment1completed
NCT00875615
Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgerytreatment2completed
NCT00310115
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyNo drug interventionsNot AvailableNot Availablecompleted
NCT06251115
Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01522937
A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic CancerNo drug interventionstreatment2completed
NCT05343832
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00652132
Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancertreatment3completed
NCT05128032
Pressure-enabled Delivery in Radioembolization (TriNav Study)No drug interventionsdiagnosticNot Availablerecruiting
NCT04445532
Hepatobiliary Tumors Tissue Samples AcquisitionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03515252
Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung CancerNo drug interventionstreatment1completed
NCT03946852
Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ TransplantationNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01353300
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00282100
Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinomaprevention2unknown_status
NCT05717400
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapytreatment4recruiting
NCT02841800
Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary StenosisNo drug interventionstreatmentNot Availablecompleted
NCT02853500
Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver MalignanciestreatmentNot Availablerecruiting
NCT03888859
ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular CarcinomaNo drug interventionstreatment0completed
NCT05199259
Multi-analyte Blood Test Clinical TrialNo drug interventionsNot AvailableNot Availablerecruiting
NCT00041275
Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgerytreatment3completed
NCT02772575
A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)No drug interventionsNot AvailableNot Availablewithdrawn
NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsNo drug interventionstreatment0recruiting
NCT02989870
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinomatreatment1withdrawn
NCT00994370
Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRTNo drug interventionsNot AvailableNot Availablecompleted
NCT02541370
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133No drug interventionstreatment1 / 2completed
NCT05743842
TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment PlanningNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT04371042
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05633342
Project CADENCE (CAncer Detected Early caN be CurEd)No drug interventionsNot AvailableNot Availablerecruiting
NCT00077142
TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)No drug interventionstreatment1 / 2completed
NCT04269499
Real-time Imaging of Holmium Radioembolization: a Feasibility StudyNo drug interventionstreatmentNot Availablecompleted
NCT00576199
A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancertreatment2completed
NCT01005199
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancertreatment2completed
NCT02012699
Integrated Cancer Repository for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT05804799
Liver CT Dose Reduction With Deep Learning Based ReconstructionNo drug interventionsNot AvailableNot Availablecompleted
NCT03844399
(3D) Ultrasound Imaging Liver and KidneyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00006006
Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removedtreatment2completed
NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT05926336
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Actiontreatment4recruiting
NCT05622136
Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinomatreatment2recruiting
NCT00767936
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableterminated
NCT00732836
Hepatic Arterial Infusion (HAI) of Abraxanetreatment1completed
NCT00614913
Proton Beam Therapy for Treatment of Hepatocellular CarcinomaNo drug interventionstreatment1 / 2completed
NCT00019513
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomastreatment1completed
NCT06557213
a Cohort Study (Gut Microbiota and HCC)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01075113
Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancertreatment1completed
NCT06003218
Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver AblationpreventionNot Availablerecruiting
NCT01853618
Tremelimumab With Chemoembolization or Ablation for Liver Cancertreatment1 / 2completed
NCT03668418
Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosNot AvailableNot Availableunknown_status
NCT03552718
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.No drug interventionstreatment1active_not_recruiting
NCT05744219
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trialtreatment3not_yet_recruiting
NCT03183219
Safety and Efficiency of γδ T Cell Against Liver CancerNo drug interventionstreatment1 / 2completed
NCT04272619
Liver Cancer Community EducationNo drug interventionspreventionNot Availablecompleted
NCT04874519
Registry to Collect Health Information Related to Fibrolamellar CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05339919
Relationship Between Liver Cancer and SarcopeniaNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04145141
National Translational Science Network of Precision-based Immunotherapy for Primary Liver CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04476641
A Study of DC-CIK Immunotherapy in the Treatment of Solid TumorsNo drug interventionstreatment2unknown_status
NCT05913141
PDO/PDO-TIL/PDOTS for Drug ScreenNo drug interventionsNot AvailableNot Availablerecruiting
NCT02869217
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumorstreatment1active_not_recruiting
NCT06384417
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2No drug interventionssupportive_careNot Availablerecruiting
NCT01658917
Collecting Solid Tumor Tissue to Identify New TreatmentsNo drug interventionsNot AvailableNot Availablecompleted
NCT01076517
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableapproved_for_marketing
NCT05443217
Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic TreatmentsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04825834
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)No drug interventionsNot AvailableNot Availablerecruiting
NCT04186234
SBRT for Liver Cancer Before Liver TransplantationNo drug interventionstreatmentNot Availableunknown_status
NCT00022334
Vaccine Therapy in Treating Patients With Liver CancerNo drug interventionstreatment1 / 2completed
NCT06563934
Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)treatment2not_yet_recruiting
NCT00555334
Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinomatreatment4unknown_status
NCT01082224
Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS PolicydiagnosticNot Availableactive_not_recruiting
NCT00012324
Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancertreatment3completed
NCT00003424
Tamoxifen in Treating Patients With Primary Liver Cancertreatment3completed
NCT01434524
Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino AcidspreventionNot Availablecompleted
NCT03620916
Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver ResectionNo drug interventionstreatmentNot Availableunknown_status
NCT00524316
Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgerytreatment2terminated
NCT02722616
Ultrasound Monitoring of Abdominal Soft TissueNo drug interventionsdiagnosticNot Availableterminated
NCT02038296
Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular CarcinomaNo drug interventionstreatment3completed
NCT00003296
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancertreatment2unknown_status
NCT00903396
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancersupportive_care2terminated
NCT00024258
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumorstreatment2completed
NCT05724563
Domvanalimab and Zimberelimab in Advanced Liver Cancerstreatment2recruiting
NCT02447263
HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver CancerNo drug interventionstreatment1 / 2completed
NCT00482586
Quality of Life in Patients With Liver Cancer Treated With Image-Guided TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02264886
Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal MalignanciesNo drug interventionstreatment1completed
NCT01185639
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung CancerNo drug interventionstreatmentNot Availablecompleted
NCT00980239
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Livertreatment1completed
NCT02489422
Programs To Support You During ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00495625
Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)treatment2terminated
NCT03226925
Mechanically-assisted Ventilation in the Treatment of Moving Tumours With Photon and Proton TherapiesNo drug interventionsbasic_scienceNot Availablecompleted
NCT00788125
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumorstreatment1 / 2terminated
NCT00956930
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgerytreatment2completed
NCT02013830
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancertreatment2completed
NCT05850130
Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT03168230
Impact of PVE on Patient's Long-term Survival, Complications and Cancer Recurrence.No drug interventionsNot AvailableNot Availablecompleted
NCT05443230
Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 TreatmentNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00387348
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancersupportive_care3terminated
NCT00093548
Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancertreatment1 / 2withdrawn
NCT00004248
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgerytreatment2completed
NCT04545957
Jump: MR Simulation For Radiation Therapy Master ProtocolNo drug interventionstreatmentNot Availablerecruiting
NCT02029157
A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)treatment3completed
NCT01030757
Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the LiverNo drug interventionstreatment2terminated
NCT00866957
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)No drug interventionsNot AvailableNot Availablecompleted
NCT04634357
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinomatreatment1 / 2recruiting
NCT06178926
Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency AblationtreatmentNot Availablerecruiting
NCT04413526
Radiofrequency-assisted Liver Resection in Intractable Liver CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00003926
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumorssupportive_care1terminated
NCT02811666
Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive CancersNo drug interventionspreventionNot Availableunknown_status
NCT01238666
Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation ProceduresNo drug interventionsNot AvailableNot Availablecompleted
NCT06173466
Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasonetreatment4completed
NCT03475966
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation ProgramNo drug interventionssupportive_careNot Availableunknown_status
NCT02984566
Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)No drug interventionstreatmentNot Availableactive_not_recruiting
NCT02461966
Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile DeltaNo drug interventionspreventionNot Availablecompleted
NCT03408665
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00482365
National Registry and Blood Bank of Patients With Liver CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05044065
Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)No drug interventionssupportive_careNot Availablerecruiting
NCT00579865
Quality Of Life in Patients With Malignant Biliary ObstructionNo drug interventionsNot AvailableNot Availablecompleted
NCT02169765
HR Versus RFA for Early Stage HCCNo drug interventionstreatment3unknown_status
NCT00059865
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancertreatment1 / 2completed
NCT06013774
Interventional X-ray and Scintigraphy Imaging of 99mTc-MAA During the Radioembolisation Pretreatment ProcedureNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT05860374
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid TumorsNo drug interventionstreatment0recruiting
NCT05471674
Neoadjuvant Anti-PD1 in HCCtreatment2completed
NCT00020774
SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancertreatment2withdrawn
NCT00019474
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancertreatment2completed
NCT05360420
Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical ProcedureNo drug interventionsdiagnosticNot Availablerecruiting
NCT05718882
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCCtreatmentNot Availablerecruiting
NCT04502082
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)treatment1 / 2terminated
NCT00087282
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancertreatment2completed
NCT06114082
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (IDADOX)No drug interventionstreatment2recruiting
NCT03164382
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinomatreatment3completed
NCT03949231
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular CarcinomaNo drug interventionstreatment3recruiting
NCT05951231
Liver Transplantation After ex Vivo Liver PerfusionNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00019331
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumorstreatment2completed
NCT03644173
Personal Resilience Empowerment Program StudyNo drug interventionssupportive_careNot Availablecompleted
NCT00003427
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancertreatment1completed
NCT05510427
Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplificationtreatment1withdrawn
NCT02324127
Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT06146127
Precision Medicine for Combined Hepatocellular-CholangiocarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00287976
Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastomatreatment2unknown_status
NCT04843176
Artificial Intelligence vs. LIRADS in Diagnosing HCC on CTNo drug interventionsdiagnosticNot Availablerecruiting
NCT01324076
Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgerytreatment3unknown_status
NCT00374660
Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumorstreatment1 / 2completed
NCT05192460
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00467194
Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgerytreatment1completed
NCT00081094
Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00777894
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryNo drug interventionstreatment1 / 2completed
NCT04715191
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumorstreatment1recruiting
NCT03338062
A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation TherapyNo drug interventionsdiagnosticNot Availablecompleted
NCT00624962
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid TumorsNo drug interventionssupportive_careNot Availablewithdrawn
NCT04105062
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric SurgeryNo drug interventionsdiagnostic1 / 2withdrawn
NCT02834780
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinomatreatment1completed
NCT00057980
Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinomatreatment1 / 2completed
NCT00426829
Proton Therapy and Bevacizumab for Primary Liver Tumorstreatment1terminated
NCT00047229
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)treatment2completed
NCT00335829
Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgerytreatment2completed
NCT03058289
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6treatment1 / 2completed
NCT00095992
SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancertreatment2completed
NCT04618692
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver TransplantationNo drug interventionstreatmentNot Availablecompleted
NCT06406244
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing HepatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT02261844
Resveratrol and Human Hepatocyte Function in CancerNo drug interventionsbasic_science1 / 2withdrawn
NCT04257240
Recurrence of Liver Malignancy After Ischemia/Reperfusion InjuryNo drug interventionsNot AvailableNot Availablecompleted
NCT00532740
Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT01033240
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancertreatment2completed
NCT04409340
Viscoelasticity Imaging to Assess Liver CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00941967
Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancertreatment2completed
NCT01079767
Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosistreatment2terminated
NCT00896467
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT04653701
Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCCNo drug interventionsNot AvailableNot Availableunknown_status
NCT00534001
Bupropion in Helping Adults Stop Smokingother2completed
NCT01009801
Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancertreatment1 / 2terminated
NCT00004604
Biological Therapy in Treating Patients With Metastatic CancerNo drug interventionstreatment1completed
NCT00910572
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaNo drug interventionstreatment2completed
NCT01182272
Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgerytreatment2unknown_status
NCT04576572
Comparison of Criteria for Liver Transplantation in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00767468
Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosistreatment1terminated
NCT02649868
LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic TumorsNo drug interventionsdevice_feasibilityNot Availableterminated
NCT02185768
Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE IItreatment2completed
NCT00027768
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver CancerNo drug interventionstreatment3unknown_status
NCT00790569
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingpreventionNot Availablecompleted
NCT05638269
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in ChinaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01882946
Safety and Efficacy Study of DCVax-Direct in Solid TumorsNo drug interventionstreatment1 / 2unknown_status
NCT05394246
Fluorescent-labeled IgG for Liver Tumor DetectionNo drug interventionsdiagnosticNot Availablerecruiting
NCT06289712
Evaluation of the Ablation of Hepatic Lesions by ElectroporationNo drug interventionsNot AvailableNot Availablerecruiting
NCT01341210
Observational Study of the Decision Making Towards Clinical Trials in Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01011010
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgerytreatment1completed
NCT04597710
Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome SequencingNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01334710
A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancertreatment2terminated
NCT00530010
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05732181
The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency AblationtreatmentNot Availablecompleted
NCT01033695
Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph NodesNo drug interventionsNot AvailableNot Availablecompleted
NCT03213314
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver MalignanciesNo drug interventionsdiagnosticNot Availablecompleted
NCT05462314
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal MalignanciesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00892255
Microwave Ablation of Resectable Liver TumorsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03349255
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular CarcinomaNo drug interventionstreatment1terminated
NCT02424955
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response EvaluationdiagnosticNot Availablecompleted
NCT00002655
Cryosurgery in Treating Patients With Liver Cancer or Liver MetastasesNo drug interventionstreatment2completed
NCT01387555
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenibtreatment2completed
NCT01075555
Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosistreatment3completed
NCT00020150
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumorstreatment1completed
NCT06342323
The Optimal Number of Fiducial Marker for Stereotactic Body RadiotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06356623
A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00003923
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreastreatment2completed
NCT02966223
A Study to Assess the Effect of Y-90 Therapy on Non-target/Background LiverNo drug interventionsdiagnosticNot Availableterminated
NCT00002608
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumorstreatment2completed
NCT01402908
A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resectiontreatment3terminated
NCT00030108
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapytreatment1completed
NCT06006338
3D Printed Models for Liver SurgeryNo drug interventionsdevice_feasibility1recruiting
NCT05187338
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumorstreatment1 / 2recruiting
NCT04195438
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyNo drug interventionsotherNot Availablecompleted
NCT00902343
Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic ResectionNo drug interventionstreatment3completed
NCT03026803
A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancertreatment2terminated
NCT01237990
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic ProceduresNo drug interventionsNot AvailableNot Availablecompleted
NCT02232490
Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-Ltreatment3unknown_status
NCT06141564
Detect and Expunge Concealed Tumors of the LiverNo drug interventionsNot AvailableNot Availablerecruiting
NCT06447064
Cancer Loyalty Card Study 2 (CLOCS-2)No drug interventionsNot AvailableNot Availablerecruiting
NCT03739164
Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02202564
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinomatreatment2completed
NCT00899002
Biomarkers in Stored Tumor Samples From Younger Patients With Liver CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01283802
Intraoperative Cholangio-Ultrasound in Resective Liver SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00873002
Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgerytreatment1terminated
NCT02321202
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancerprevention4completed
NCT00242502
Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgerytreatment2completed
NCT01164202
Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancertreatment2 / 3completed
NCT00906984
TheraSphere® for Treatment of Unresectable Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableapproved_for_marketing
NCT00363584
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancertreatment3completed
NCT04589884
Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy AssessmentNo drug interventionsNot AvailableNot Availableterminated
NCT02333279
Cancer Development In Organ Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNo drug interventionstreatment1 / 2completed
NCT01024530
Phase II/III Trial of Hepatocellular Carcinoma Patients Treated by ex Vivo Expanded Autologous Immune Killer Cells as the Adjunct TherapyNo drug interventionssupportive_care2 / 3unknown_status
NCT02690350
An Open Study Assessing the Safety and Tolerability of U3-1784No drug interventionstreatment1terminated
NCT04340193
A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancertreatment3terminated
NCT06144827
A Pilot Study For Patients Receiving Radiation Therapy for Liver CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03586050
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in KoreaNo drug interventionstreatmentNot Availablecompleted
NCT01929902
Evaluation of Efficacy and Accuracy of Aquamantys Device in General SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT03299036
Drug-loadable(T-ACE Beads)for Hepatoma Embolization TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04258813
Onco-primary Care Networking to Support TEAM-based CareNo drug interventionspreventionNot Availablerecruiting
NCT02044224
Effects of Dexmedetomidine During IRE Procedures for Solid Tumourstreatment4completed
NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)No drug interventionsNot AvailableNot Availablecompleted
NCT00730860
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACENo drug interventionstreatmentNot Availableunknown_status
NCT01627808
Fluid Optimization in Liver SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT04348838
Prospective Cohort of Patients With Hepatocellular Carcinoma in FranceNo drug interventionsNot AvailableNot Availablerecruiting
NCT05030090
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal CancertreatmentNot Availablecompleted
NCT05643833
Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT06458998
Getting To Implementation: Improving Cancer Screening for VeteransNo drug interventionshealth_services_researchNot Availableenrolling_by_invitation
NCT01657383
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00216437
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinomatreatment1terminated
NCT05109052
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinomatreatment1 / 2withdrawn
NCT02145559
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumorstreatment1completed
NCT05179824
Tempus Priority Study: A Pan-tumor Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03323996
Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)No drug interventionsNot AvailableNot Availableunknown_status
NCT05041335
Wet Heparinized Suction for Abdominal CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT03766776
Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)treatmentNot Availableunknown_status
NCT02016391
Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumourstreatment4completed
NCT03347162
Muscle Dysfunction in Gastrointestinal or Hepatobiliary CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05907772
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT04172714
Low-dose Y90 Treatment Planning for HCCNo drug interventionstreatmentNot Availablecompleted
NCT02825550
Taiwan ACE Beads for Hepatoma Embolization TherapyNo drug interventionstreatmentNot Availablecompleted
NCT03607643
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignanciestreatment1 / 2unknown_status
NCT04692454
Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic CancersNo drug interventionspreventionNot Availablecompleted
NCT03474354
DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablecompleted
NCT05070247
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT01078311
Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00813293
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancertreatment2completed
NCT05701488
SIRT With Tremelimumab and Durvalumab for Resectable HCCtreatment1recruiting
NCT01849588
HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)treatment4terminated
NCT02288507
Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancertreatment1withdrawn
NCT04033107
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumorstreatment2recruiting
NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT01807156
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancertreatment2terminated
NCT03037437
Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancertreatment2active_not_recruiting
NCT01801852
Autologous Natural Killer T Cells Infusion for the Treatment of CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03480152
Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous CancerNo drug interventionstreatment1 / 2terminated
NCT02482259
Assessment of Frailty in Patients With Advanced Hepatocellular CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT01619475
Adult-to-Adult Living Donor Transplant Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03253536
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT01655641
Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgerytreatment2 / 3unknown_status
NCT05293496
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumorstreatment1recruiting
NCT00909558
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerNo drug interventionstreatment1suspended
NCT02073435
A2ALL-Patients Safety System Improvements in Living Donor Liver TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT03926039
Sharing Decision-making Program for HCC Patients Treatment DecisionsNo drug interventionsotherNot Availablecompleted
NCT00997022
Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patientstreatment1completed
NCT02528526
Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary NeoplasmNo drug interventionstreatment1 / 2unknown_status
NCT04912765
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRCtreatment2recruiting
NCT04212273
Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCCNo drug interventionsdiagnosticNot Availablerecruiting
NCT03748927
Natural History Study of Children and Adults With Fibrolamellar Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01012362
Study of Pazopanib and Ixabepilone in Patients With Solid Tumorstreatment1terminated
NCT01507740
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer PatientsNot AvailableNot Availableterminated
NCT04166240
Measuring and Improving the Safety of Test Result Follow-UpNo drug interventionshealth_services_researchNot Availablecompleted
NCT03785210
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancerstreatment2completed
NCT02082210
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancertreatment1 / 2completed
NCT05003895
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)treatment1recruiting
NCT00465023
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic MetastasesNo drug interventionstreatmentNot Availablecompleted
NCT01967823
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancertreatment2completed
NCT04620538
Volatile Organic Compounds for the Assessment of Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05451043
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)treatment2recruiting
NCT02787954
Prospective Tumor Response EvaluationNo drug interventionsNot AvailableNot Availableterminated
NCT04264754
Characterization of Methylation Patterns in Hepatocellular CarcinomaNo drug interventionsNot AvailableNot Availableterminated
NCT03551951
Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowNo drug interventionsNot AvailableNot Availablerecruiting
NCT05185505
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteriatreatment4recruiting
NCT05453383
Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinibtreatment2unknown_status
NCT01456156
Study of Postoperative 3D-CRT/IMRT in Hepatocellular CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT00878215
Clinical Application of Image-Guided Liver SurgeryNo drug interventionstreatment2terminated
NCT05061537
Study of PF-07263689 in Participants With Selected Advanced Solid Tumorstreatment1terminated
NCT03195699
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancerstreatment1active_not_recruiting
NCT02141906
A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of DoxorubicinNo drug interventionstreatment2completed
NCT04484636
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)No drug interventionsotherNot Availablerecruiting
NCT03151213
Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Livertreatment4unknown_status
NCT01486134
Major RF Ablations of Hepatomas Under MR Thermometry MonitoringNo drug interventionstreatmentNot Availableterminated
NCT02958163
Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)treatment2terminated
NCT04212286
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCCNo drug interventionsdiagnosticNot Availablecompleted
NCT03937830
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinomatreatment2recruiting
NCT02947165
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.treatment1completed
NCT05438420
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumorstreatment1 / 2recruiting
NCT05100082
Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular CarcinomaNot AvailableNot Availableactive_not_recruiting
NCT02929082
Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03572582
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinomatreatment2completed
NCT00706576
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factortreatment1completed
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT02954094
A Longitudinal Observational Study of the Natural History and Management of Patients With HCCNo drug interventionsNot AvailableNot Availablerecruiting
NCT03594929
Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT02616692
HCC Patient Preferences in JapanNot AvailableNot Availablecompleted
NCT03132792
AFPᶜ³³²T in Advanced HCCNo drug interventionstreatment1active_not_recruiting
NCT01775501
Sorafenib + mFOLFOX for Hepatocellular Carcinomatreatment2completed
NCT03971201
A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasiontreatment2unknown_status
NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapytreatment1 / 2recruiting
NCT01375569
TRC105 for Liver Cancer That Has Not Responded to Sorafenibtreatment2completed
NCT05489250
The PLATON NetworkNo drug interventionsNot AvailableNot Availablerecruiting
NCT05361538
Study of Microwave Spherical Ablation and Traditional Microwave Ablation in Single Hepatocellular Carcinoma ≤5cmNo drug interventionstreatmentNot Availablerecruiting